Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison

Authors

  • Jessica F. Burlile Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA https://orcid.org/0000-0001-8653-1045
  • Satomi Shiraishi Mayo Clinic Department of Medical Physics, Rochester, MN, USA https://orcid.org/0000-0002-9522-014X
  • Heather J. Gunn Mayo Clinic Department of Quantitative Health Sciences, Rochester, MN, USA https://orcid.org/0000-0001-8665-2867
  • Jennifer L. Bradt Mayo Clinic Department of Rehabilitation, Rochester, MN, USA
  • Haley M. Kroeplin Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA
  • Karen G. Lang Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA
  • Jenna K. Cimmiyotti Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA
  • Nicolas Depauw Massachusetts General Hospital Department of Radiation Oncology, Boston, MA, USA
  • Connie Y. Chang Massachusetts General Hospital Department of Radiology, Boston, MA, USA
  • Kevin M. Brom Mayo Clinic Department of Medical Physics, Rochester, MN, USA
  • Cassandra L. Sonnicksen Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA
  • Anhmai Vu Mayo Clinic Alix School of Medicine, Rochester, MN, USA
  • Rachel B. Jimenez Massachusetts General Hospital Department of Radiation Oncology, Rochester, MN, USA https://orcid.org/0000-0001-7368-1204
  • Kimberly S. Corbin Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA https://orcid.org/0000-0002-3880-9791

DOI:

https://doi.org/10.2340/1651-226X.2024.40084

Keywords:

dosimetry, proton therapy, dose comparison, musculoskeletal dysfunction, frozen shoulder, myofascial pain, breast cancer, regional nodal irradiation, comprehensive nodal irradiation

Abstract

Background and purpose: Regional nodal irradiation (RNI) for breast cancer delivers radiation in proximity to the shoulder and torso, and radiation exposure may contribute to long-term upper extremity and postural morbidity. To date, no studies have assessed the differential dosimetric impact of proton versus photon radiation on shoulder and torso anatomy. This study examined clinically relevant musculoskeletal (MSK) structures and assessed the dose delivered with each modality.

Patients/material and methods: Ten MSK structures were contoured on IMPT (intensity-modulated proton therapy) and VMAT (volumetric modulated arc therapy) plans for 30 patients receiving RNI. Relevant dose metrics were compared for each of the structures. Intensity-modulated proton therapy dose was calculated using the relative biological effective value of 1.1. Hypo-fractionated plans were scaled to the equivalent dose in 2 Gy fractions (EQD2) using an alpha/beta ratio of four. Wilcoxon signed rank sum tests compared doses. Select three-dimensional and optimised VMAT plans were also informally compared.

Results and interpretation: Each of the 10 structures received a statistically significantly lower dose with the use of IMPT compared with VMAT. Differences were greatest for posterior structures, including the trapezius, latissimus dorsi and glenohumeral joint. Mean absolute differences were as great as 23 Gy (supraspinatus D5cc) and up to 30-fold dose reductions were observed (deltoid D50cc). An average 3.7-fold relative dose reduction existed across all structures. Measures of low/intermediate dose (V15Gy and D50cc) showed the largest differences.

Intensity-modulated proton therapy results in statistically lower radiation exposure to relevant shoulder and torso anatomy compared to photon radiation for patients requiring RNI. Prospective study is needed to correlate functional outcomes with radiation dose.

Downloads

Download data is not yet available.

References

National Cancer Institute, Surveillance, Epidemiology, and End Results Program (SEER). Common cancer sites – cancer stat facts [Internet]. [cited 08-12-2023]. Available from: https://seer.cancer.gov/statfacts/html/common.html

Breast Cancer Research Foundation (BCRF). Breast cancer statistics and resources [Internet]. Breast Cancer Research Foundation; 2021 [cited 08-09-2022]. Available from: https://www.bcrf.org/breast-cancer-statistics-and-resources

Rosenberg PS, Barker KA, Anderson WF. Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States. J Natl Cancer Inst. 2015;107:djv159.

https://doi.org/10.1093/jnci/djv159 DOI: https://doi.org/10.1093/jnci/djv159

Gärtner R, Jensen M-B, Kronborg L, et al. Self-reported arm-lymphedema and functional impairment after breast cancer treatment – a nationwide study of prevalence and associated factors. Breast. 2010;19:506–15.

https://doi.org/10.1016/j.breast.2010.05.015 DOI: https://doi.org/10.1016/j.breast.2010.05.015

Rangel J, Perez CS, Oliveira R, et al. Effects of breast cancer treatment on posture: a current review. Int J Phys Ther Rehabil. 2019;5:152.

https://doi.org/10.15344/2455-7498/2019/152 DOI: https://doi.org/10.15344/2455-7498/2019/152

Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959–72.

https://doi.org/10.1245/s10434-009-0452-2 DOI: https://doi.org/10.1245/s10434-009-0452-2

Hidding JT, Beurskens CHG, van der Wees PJ, et al. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One. 2014;9:e96748.

https://doi.org/10.1371/journal.pone.0096748 DOI: https://doi.org/10.1371/journal.pone.0096748

Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R. 2011;3:1041–54.

https://doi.org/10.1016/j.pmrj.2011.08.535 DOI: https://doi.org/10.1016/j.pmrj.2011.08.535

Johansen S, Fosså K, Nesvold IL, et al. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol Stockh Swed. 2014;53:521–9.

https://doi.org/10.3109/0284186X.2014.880512 DOI: https://doi.org/10.3109/0284186X.2014.880512

Gebre-Medhin M, Haghanegi M, Robért L, et al. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncol Stockh Swed. 2016;55:1313–17.

https://doi.org/10.1080/0284186X.2016.1221129 DOI: https://doi.org/10.1080/0284186X.2016.1221129

Paulino AC. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60:265–74.

https://doi.org/10.1016/j.ijrobp.2004.02.001 DOI: https://doi.org/10.1016/j.ijrobp.2004.02.001

Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol. 2002;53:407–21.

https://doi.org/10.1016/S0360-3016(02)02754-2 DOI: https://doi.org/10.1016/S0360-3016(02)02754-2

Wan Chan Tseung H, Ma J, Beltran C. A fast GPU-based Monte Carlo simulation of proton transport with detailed modeling of nonelastic interactions. Med Phys. 2015;42:2967–78.

https://doi.org/10.1118/1.4921046 DOI: https://doi.org/10.1118/1.4921046

Gillette EL, Mahler PA, Powers BE, et al. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol. 1995;31:1309–18.

https://doi.org/10.1016/0360-3016(94)00422-H DOI: https://doi.org/10.1016/0360-3016(94)00422-H

Agrawal S. Late effects of cancer treatment in breast cancer survivors. S Asian J Cancer. 2014;3:112–15.

https://doi.org/10.4103/2278-330X.130445 DOI: https://doi.org/10.4103/2278-330X.130445

Henry NL, Kim S, Hays RD, et al. Toxicity index, patient-reported outcomes, and persistence of breast cancer chemotherapy- associated side effects in NRG Oncology/NSABP B-30. Npj Breast Cancer. 2022;8:1–7.

https://doi.org/10.1038/s41523-022-00489-9 DOI: https://doi.org/10.1038/s41523-022-00489-9

Smoot B, Paul SM, Aouizerat BE, et al. Predictors of altered upper extremity function during the first year after breast cancer treatment. Am J Phys Med Rehabil Assoc Acad Physiatr. 2016;95:639–55.

https://doi.org/10.1097/PHM.0000000000000455 DOI: https://doi.org/10.1097/PHM.0000000000000455

Straub JM, New J, Hamilton CD, et al. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141:1985–94.

https://doi.org/10.1007/s00432-015-1974-6 DOI: https://doi.org/10.1007/s00432-015-1974-6

McNeely ML, Campbell K, Ospina M, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev. 2010;(6):CD005211.

https://doi.org/10.1002/14651858.CD005211.pub2 DOI: https://doi.org/10.1002/14651858.CD005211.pub2

Richmond H, Lait C, Srikesavan C, et al. Development of an exercise intervention for the prevention of musculoskeletal shoulder problems after breast cancer treatment: the prevention of shoulder problems trial (UK PROSPER). BMC Health Serv Res. 2018;18:463.

https://doi.org/10.1186/s12913-018-3280-x DOI: https://doi.org/10.1186/s12913-018-3280-x

Levy EW, Pfalzer LA, Danoff J, et al. Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat. 2012;134:315–24.

https://doi.org/10.1007/s10549-012-2061-1 DOI: https://doi.org/10.1007/s10549-012-2061-1

Appelgren M, Sackey H, Wengström Y, et al. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial. Breast Off J Eur Soc Mastol. 2022;63:16–23.

https://doi.org/10.1016/j.breast.2022.02.013 DOI: https://doi.org/10.1016/j.breast.2022.02.013

Bartels SAL, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial. J Clin Oncol. 2023;41(12):2159–65.

https://doi.org/10.1200/JCO.22.01565 DOI: https://doi.org/10.1200/JCO.22.01565

Min J, Kim JY, Yeon S, et al. Change in shoulder function in the early recovery phase after breast cancer surgery: a prospective observational study. J Clin Med. 2021;10:3416.

https://doi.org/10.3390/jcm10153416 DOI: https://doi.org/10.3390/jcm10153416

Yang S, Park DH, Ahn SH, et al. Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment. Support Care Cancer. 2017;25:1317–22.

https://doi.org/10.1007/s00520-016-3532-4 DOI: https://doi.org/10.1007/s00520-016-3532-4

Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, et al. Development of active myofascial trigger points in neck and shoulder musculature is similar after lumpectomy or mastectomy surgery for breast cancer. J Bodyw Mov Ther. 2012;16:183–90.

https://doi.org/10.1016/j.jbmt.2011.01.022 DOI: https://doi.org/10.1016/j.jbmt.2011.01.022

Torres Lacomba M, Mayoral del Moral O, Coperias Zazo JL, et al. Incidence of myofascial pain syndrome in breast cancer surgery: a prospective study. Clin J Pain. 2010;26:320–5.

https://doi.org/10.1097/AJP.0b013e3181c4904a DOI: https://doi.org/10.1097/AJP.0b013e3181c4904a

Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95:409–18.

https://doi.org/10.1002/jso.20782 DOI: https://doi.org/10.1002/jso.20782

Bazan JG, DiCostanzo D, Hock K, et al. Analysis of radiation dose to the shoulder by treatment technique and correlation with patient reported outcomes in patients receiving regional nodal irradiation. Front Oncol. 2021;11:617926.

https://doi.org/10.3389/fonc.2021.617926 DOI: https://doi.org/10.3389/fonc.2021.617926

Additional Files

Published

2024-10-01

How to Cite

Burlile, J. F., Shiraishi, S., Gunn, H. J., Bradt, J. L., Kroeplin, H. M., Lang, K. G., … Corbin, K. S. (2024). Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison. Acta Oncologica, 63(1), 755–762. https://doi.org/10.2340/1651-226X.2024.40084